A recent study from cancer researchers at the University of Alabama at Birmingham and Georgia State University has identified a new therapeutic target in quadruple-negative breast cancer, or QNBC, one of the deadliest and most aggressive treatment-resistant forms of breast cancer.
Don’t try to convince Col. Susan Fondy that lymphedema doesn’t merit interest from medical researchers.
